Clinical use of the measurement of soluble cell adhesion molecules in patients with autoimmune rheumatic diseases

Clinical and Diagnostic Laboratory Immunology

Volumn 4, Issue 3, 1997, Pages 241-246

  Sfikakis, P P ^a   Tsokos, G C ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; L SELECTIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1;

AUTOIMMUNITY; CELL ADHESION; DIAGNOSIS; DIAGNOSTIC VALUE; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS;

EID: 0030916645     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.4.3.241-246.1997     Document Type: Review

References (50)

1. Aoki, S., K. Imai, and A. Yachi. 1993. Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand. J. Immunol. 38:485-490.
2. Aydintug, A. O., G. Tokgoz, K. Ozoran, N. Duzgun, A. Gurler, and H. Tukak. 1995. Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behcet's disease. Rheumatol. Int. 15:75-78.
3. Becker, J. C., C. Termeer, R. E. Schmidt, and E. B. Brocker. 1993. Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/ tumor interaction. J. Immunol. 151:7224-7232.
4. Belmont, H. M., J. Buyon, R. Giorno, and S. Abramson. 1994. Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus. The Shwartzman phenomenon revisited. Arthritis Rheum. 37:376-383.
5. Blann, A. D., R. J. Daly, and J. Amiral. 1996. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br. J. Haematol. 92:498-500.
6. Blann, A. D., C. N. McCollum, M. Steiner, and M. I. V. Jayson. 1995. Circulating adhesion molecules in inflammatory and atherosclerotic vascular disease. Immunol. Today 16:251-252.
7. Bloom, B. J., L. B. Ticker, L. C. Miller, J. G. Schaller, and P. R. Blier. 1996. Soluble adhesion molecules in juvenile rheumatoid arthritis. Arthritis Rheum. 39(Suppl. 9):S53.
8. Bruijn, J. A., and N. J. Dinklo. 1993. Distinct patterns of expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 in renal disease. Lab. Invest. 69: 329-335.
9. Carson, C. W., L. D. Beall, G. G. Hunder, C. M. Johnson, and W. Newman. 1993. Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J. Rheumatol. 20:809-814.
10. Claman, H. N., R. C. Giorno, and J. R. Seibold. 1991. Endothelial and fibroblastic activation in scleroderma. The myth of the uninvolved skin. Arthritis Rheum. 34:1495-1501.
11. Coll-Vinenc, B., M. C. Cid, J. M. Grau, A. Lopez-Soto, J. Oritrell, C. Font, X. Bosch, E. Mirapeiz, and A. Urbano-Marquez. 1995. Soluble intercellular adhesion molecule-1, vascular adhesion molecule-1, E-selectin and L-selectin in polyarteritis nodosa. Arthritis Rheum. 38(Suppl. 9):S156.
12. Cush, J. J., R. Rothlein, H. B. Lindsley, E. A. Mainolfi, and P. E. Lipsky. 1993. Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum. 36:1098-1102.
13. Denton, C. P., M. C. Bickerstaff, X. M. Shiwen, T. Carulli, D. O. Haskard, R. M. Dubois, and C. M. Black. 1995. Serial circulating adhesion molecule levels reflect disease activity in systemic sclerosis. Br. J. Rheumatol. 34:1048-1054.
14. Etzioni, A. 1994. Adhesion molecules in host defense. Clin. Diagn. Lab. Immunol. 1:1-4.
15. Furukawa, S., K. Imai, T. Matsubara, K. Yone, A. Yachi, K. Okumura, and K. Yabuta. 1992. Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease. Arthritis Rheum. 35:672-677.
16. Gearing, A. J., and W. Newman. 1993. Circulating adhesion molecules in disease. Immunol. Today 14:506-512.
17. Gruschwitz, M. S., O. P. Hornstein, and P. von den Driesch. 1995. Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum. 38:184-189.
18. Harlan, J. M., and D. Y. Liu (ed.). 1992. Adhesion: its role in inflammatory disease. W. H. Freeman and Co., New York, N.Y.
19. Hebbar, M., P. Lassalle, A. Janin, D. Vanhee, S. Bisiau, P. Y. Hatron, A. B. Tonnel, and B. Gosselin. 1995. E-selectin expression in salivary endothelial cells and sera from patients with systemic sclerosis. Arthritis Rheum. 38: 406-412.
20. Hoffmann, J. C., H. J. Rauker, H. Kruger, B. Bayer, and H. Zeidler. 1996. Decreased levels of a soluble form of the human adhesion receptor CD58 (LFA-3) in sera and synovial fluids of patients with rheumatoid arthritis. Clin. Exp. Rheumatol. 14:23-29.
21. Hosaka, S., M. Shah, R. M. Pope, and A. E. Koch. 1996. Soluble forms of P-selectin and intercellular adhesion molecule-3 in synovial fluids. Clin. Immunol. Immunopathol. 78:276-282.
22. Humbria, A., F. Diaz-Gonzalez, M. R. Campanero, A. G. Arroyo, A. Laffon, R. Gonzalez-Amaro, and F. Sanchez-Madrid. 1994. Expression of L-selectin, CD43, and CD44 in synovial fluid neutrophils from patients with inflammatory joint diseases. Evidence for a soluble form of L-selectin in synovial fluid. Arthritis Rheum. 37:342-348.
23. Inuzuka, H., T. Seita, K. Okamoto, K. Iida, Y. Ogawa, and S. Iwasa. 1995. A sensitive ELISA for the characterization of two forms of circulating intercellular adhesion molecule-1 in human plasma. Biol. Pharm. Bull. 18:1036-1040.
24. Janssen, B. A., R. A. Luqmani, C. Gordon, I. H. Hemingway, P. A. Bacon, A. J. Gearing, and P. Emery. 1994. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br. J. Rheumatol. 33:1112-1116.
25. Kiener, H., W. Graninger, K. Machold, M. Aringer, and W. B. Graninger. 1994. Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin. Exp. Rheumatol. 12:483-487.
26. Kitani, A., N. Nakashima, T. Matsuda, B. Xu, S. Yu, T. Nakamura, and T. Matsuyama. 1996. T cells bound by vascular cell adhesion molecule-1/CD106 in synovial fluid in rheumatoid arthritis: inhibitory role of soluble vascular cell adhesion molecule-1 in T cell activation. J. Immunol. 156:2300-2308.
27. Kling, E., S. Bieg, M. Boehme, and W. A. Scherbaum. 1993. Circulating intercellular adhesion molecule-1 as a new activity marker in patients with systemic lupus erythematosus. Clin. Invest. 71:299-304.
28. Koch, A. E., M. R. Shah, L. A. Harlow, R. M. Lovis, and R. M. Pope. 1994. Soluble intercellular adhesion molecule-1 in arthritis. Clin. Immunol. Immunopathol. 71:208-215.
29. Koch, A. E., W. Turkiewitcz, L. A. Harlow, and R. M. Pope. 1993. Soluble E-selectin in arthritis. Clin. Immunol. Immunopathol. 69:29-35.
30. Lhotta, K., H. P. Neumayer, M. Joannidis, D. Geissler, and P. Konig. 1991. Renal expression of intercellular adhesion molecule-1 in different forms of glomerulonephritis. Clin. Sci. (Colchester) 81:477-481.
31. Machold, K. P., H. P. Kiener, and W. B. Graninger. 1993. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin. Immunol. Immunopathol. 68:74-78.
32. Mason, J. C., P. Kapachi, and D. O. Haskard. 1993. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum. 36:519-527.
33. Meager, A., C. Bird, and A. Mire-Sluis. 1996. Assays for measuring soluble cellular adhesion molecules and soluble cytokine receptors. J. Immunol. Methods 191:97-112.
34. Nash, M. C., V. Shah, and M. J. Dillon. 1995. Soluble adhesion molecules and von-Willebrand factor in children with Kawasaki disease. Clin. Exp. Immunol. 101:13-17.
35. Nash, M. C., A. M. Wade, V. Shah, and M. J. Dillon. 1996. Normal levels of soluble E-selectin, soluble intercellular adhesion molecule-1 (ICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease with age. Clin. Exp. Immunol. 103:167-170.
36. Paleolog, E. M., M. Hunt, M. J. Elliot, M. Feldmann, R. N. Maini, and J. N. Woody. 1996. Deactivation of vascular endothelium by monoclonal antitumor necrosis factor a antibody in rheumatoid arthritis. Arthritis Rheum. 39:1371-1375.
37. Pigot, R., and C. Power. 1993. The adhesion molecule facts book. Academic Press, San Diego, Calif.
38. Pino-Otin, M. R., O. Vinas, M. A. de la Fuente, M. Juan, J. Font, M. Torradeflot, L. Pallares, F. Lozano, J. Alberola-Ila, and J. Martorell. 1995. Existence of a soluble form of CD50 (ICAM-3) produced upon human lymphocyte activation. Present in normal human serum and levels are increased in the serum of systemic lupus erythematosus patients. J. Immunol. 154:3015-3024.
39. Sfikakis, P. P., D. Charalambopoulos, G. Vaiopoulos, R. Oglesby, P. Sfikakis, and G. C. Tsokos. 1994. Increased levels of intercellular adhesion molecule-1 in the serum of patients with systemic lupus erythematosus. Clin. Exp. Rheumatol. 12:5-9.
40. Sfikakis, P. P., D. Charalambopoulos, G. Vaiopoulos, G. C. Tsokos, and M. Mavrikakis. Circulating L- and P-selectins and T cell activation in vivo in patients with autoimmune rheumatic diseases. Submitted for publication.
41. Sfikakis, P. P., J. Tesar, H. Barraf, R. Lipnick, G. L. Klipple, and G. C. Tsokos. 1993. Circulating intercellular adhesion molecule-1 (ICAM-1) in patients with systemic sclerosis. Clin. Immunol. Immunopathol. 68:88-92.
42. Sfikakis, P. P., J. Tesar, S. Theocharis, G. L. Klipple, and G. C. Tsokos. 1994. Increased frequency of in vivo hprt gene-mutated T cell in the peripheral blood of patients with systemic sclerosis. Ann. Rheum. Dis. 53:122-127.
43. Sfikakis, P. P., and G. C. Tsokos. 1994. Increased levels of intercellular adhesion molecule-1 in patients with systemic lupus erythematosus. Comment on the article by Mason et al. Arthritis Rheum. 37:300.
44. Sfikakis, P. P., and G. C. Tsokos. 1995. Lymphocyte adhesion molecules in autoimmune rheumatic diseases: basic issues and clinical expectations. Clin. Exp. Rheumatol. 13:764-777.
45. Sfikakis, P. P., V. Tzavara, N. Sipsas, O. Kosmopoulou, P. Sfikakis, and T. Kordosis. Levels of the circulating cell adhesion molecule E-selectin and disease progression in HIV infection. Infection, in press.
46. Shi-Wen, X., M. Panesar, R. Vancheeswaran, J. Mason, D. Haskard, C. Black, I. Olsen, and D. Abraham. 1994. Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Arthritis Rheum. 37:1689-1697.
47. Sipsas, N., P. P. Sfikakis, P. Sfikakis, E. Choremi, and T. Kordossis. 1994. Serum concentrations of soluble intercellular adhesion molecule-1 and progress towards disease in patients infected with HIV. J. Infect. 29:271-282.
48. Sondergaard, K. M., L. Deleuran, L. Heickendorff, H. Zachariae, K. Stengaard-Pederson, K. Therstrup-Peersen, and B. Deleyran. 1995. Increased soluble intercellular adhesion molecule-1 and interlcukin-2 receptors in scleroderma skin. Arthritis Rheum. 38(Suppl. 9):S254.
49. Veale, D. J., C. Maple, G. Kirk, and J. J. Belch. 1995. Soluble cell adhesion molecule levels in rheumatoid arthritis in response to sulphasalazine therapy. Arthritis Rheum. 38(Suppl. 9):S370.
50. Wang, C. R., M. F. Liu, R. T. Tsai, C. Y. Chuang, and C. Y. Chen. 1993. Circulating intercellular adhesion molecules-1 and autoantibodies including anti-endothelial cell, anti-cardiolipin, and anti-neutrophil cytoplasm antibodies in patients with vasculitis. Clin. Rheumatol. 12:375-380.